Theresa Carioti

FDA analysis of pembrolizumab trials in multiple myeloma: Immune related adverse events (irAEs) and response.

R. Pazdur, A. Rosenberg, R. Sridhara, 2018 .

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

R. Pazdur, R. Sridhara, A. Farrell, 2019, Blood.